Fujifilm Biotechnologies has opened its new manufacturing site in Holly Springs, North Carolina, which now represents one of the largest commercial-scale cell culture biomanufacturing sites in North America. The first phase of the planned $3.2 billion manufacturing site opens with a capacity of 8 x 20,000 liters (L) mammalian cell culture bioreactors to encompass drug product and drug substance manufacturing, while adding finished goods capabilities in 2026. The second phase expansion (announ...